Results 251 to 260 of about 27,408 (289)
Some of the next articles are maybe not open access.
Restenosis after Percutaneous Transluminal Coronary Angioplasty
Acta Radiologica, 1992Restenosis after percutaneous transluminal coronary angioplasty was demonstrated in 61 (29%) of 210 successfully treated patients. Mostly it occurred within 4 months after treatment and in arteries less than 3 mm in diameter. Careful clinical follow-up is therefore particularly important early after angioplasty of smaller arteries.
Svein Simonsen +2 more
openaire +3 more sources
Percutaneous transluminal coronary angioplasty in silent ischemia
American Heart Journal, 1990The short- and long-term outcome of percutaneous transluminal coronary angioplasty were analyzed in 34 patients who had documented coronary artery disease without symptoms. Of the 34 patients, 33 had abnormal stress tests before angioplasty. Angioplasty was successful in 31 patients (91%).
Jay Hollman +6 more
openaire +3 more sources
Ridogrel in the setting of percutaneous transluminal coronary angioplasty
The American Journal of Cardiology, 1991The safety of the combination of heparin and ridogrel therapy and its antiplatelet efficacy was examined in the setting of percutaneous transluminal coronary angioplasty (PTCA). In 32 patients without known aspirin intake for 10 days before PTCA, therapy with ridogrel (300-mg intravenous bolus) was begun just before PTCA and continued orally at a dose ...
Francis Stammen +13 more
openaire +3 more sources
Percutaneous transluminal coronary angioplasty for unstable angina
The American Journal of Cardiology, 1991Coronary angioplasty is an effective treatment for patients with angina at rest, either refractory or initially stabilized but returning despite pharmacologic treatment, and with early postinfarction angina. The procedure has a high initial success rate, but there is an increased risk of major complications resulting from a higher incidence of acute ...
Patrick W. Serruys +7 more
openaire +3 more sources
Changing patterns in percutaneous transluminal coronary angioplasty
American Heart Journal, 1989We analyzed the impact of evolving technology on percutaneous transluminal coronary angioplasty in 2677 patients. There were 168 patients in period 1 when fixed-wire catheters were used, 1117 patients in period 2 when steerable catheters were available, and 1392 patients in period 3 when low-profile systems were utilized.
Conrad Simpfendorfer +6 more
openaire +3 more sources
Sustained efficacy of percutaneous transluminal coronary angioplasty
American Heart Journal, 1986To determine whether the immediate efficacy of percutaneous transluminal coronary angioplasty (PTCA) is sustained, follow-up data were obtained in 183 patients who had undergone PTCA at least 1 year earlier. The duration of follow-up ranged from 1 to 5 years.
David O. Williams +7 more
openaire +3 more sources
Study of Percutaneous, Transluminal Coronary Angioplasty [PDF]
JAMA: The Journal of the American Medical Association, 1980 To the Editor.— I would like to respond to the editorial by David H. Spodick, MD (242:1658, 1979), inThe Journal, suggesting that the time is ripe for a randomized clinical trial of percutaneous, transluminal coronary angioplasty. This technique has been introduced cautiously and with rather limited acceptance to date.
openaire +1 more source
Effect of Percutaneous Transluminal Coronary Angioplasty
1985Transluminal coronary angioplasty (TCA) has proved to be successful in dilating high-grade stenotic vessel segments. Due to a reduction in the stenosis responsible for angina pectoris and ischemic reactions in the exercise ECG the patients are asymptomatic and can be fully stressed the day after angioplasty provided that complete revascularization has ...
R. Hopf +4 more
openaire +2 more sources
Percutaneous Transluminal Coronary Angioplasty
New England Journal of Medicine, 1994Charles Landau +2 more
openaire +3 more sources